Financials Diagnamed Holdings Corp.

Equities

DMED

CA25245D1033

Software

Market Closed - Canadian Securities Exchange 20:58:11 09/05/2024 BST 5-day change 1st Jan Change
0.035 CAD 0.00% Intraday chart for Diagnamed Holdings Corp. 0.00% +16.67%

Valuation

Fiscal Period: September 2023
Capitalization 1 3.202
Enterprise Value (EV) 1 2.595
P/E ratio -2.45 x
Yield -
Capitalization / Revenue -
EV / Revenue -
EV / EBITDA -
EV / FCF -3,823,205 x
FCF Yield -0%
Price to Book 13.6 x
Nbr of stocks (in thousands) 80,053
Reference price 2 0.0400
Announcement Date 30/01/24
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2021 2022 2023
Net sales - - -
EBITDA - - -
EBIT 1 -0.6837 -1.13 -1.178
Operating Margin - - -
Earnings before Tax (EBT) 1 -1.948 -1.132 -1.278
Net income 1 -1.948 -1.132 -1.278
Net margin - - -
EPS 2 -0.0349 -0.0149 -0.0163
Free Cash Flow - -0.3612 -0.6788
FCF margin - - -
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 18/01/22 30/01/23 30/01/24
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2021 2022 2023
Net Debt 1 - - -
Net Cash position 1 2.36 1.57 0.61
Leverage (Debt/EBITDA) - - -
Free Cash Flow - -0.36 -0.68
ROE (net income / shareholders' equity) - -65% -172%
ROA (Net income/ Total Assets) - -35.3% -64.6%
Assets 1 - 3.212 1.977
Book Value Per Share 2 0.0300 0.0200 0
Cash Flow per Share 2 0.0300 0.0200 0.0100
Capex - - -
Capex / Sales - - -
Announcement Date 18/01/22 30/01/23 30/01/24
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. DMED Stock
  4. Financials Diagnamed Holdings Corp.